1p21.3 microdeletion syndrome
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
2 |
|
2011 |
2011 |
Depressive personality disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Purine-Pyrimidine Metabolism, Inborn Errors
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
|
0.300 |
None |
1.000 |
2 |
|
1988 |
2004 |
Vomiting, recurrent
|
phenotype |
|
Sign or Symptom
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Poisoning by fluorouracil
|
disease |
Chemically-Induced Disorders
|
Injury or Poisoning
|
2
|
|
0.300 |
None |
|
0 |
|
|
|
Reduced dihydropyrimidine dehydrogenase activity
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Dihydropyrimidinuria
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
2 |
|
1996 |
2005 |
Cardiovascular symptoms
|
phenotype |
|
Sign or Symptom
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Transthyretin cardiac amyloidosis
|
disease |
|
Disease or Syndrome
|
3
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Long ear
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Sarcoma, Yoshida
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
6
|
|
0.200 |
None |
1.000 |
1 |
|
1993 |
1993 |
Dihydropyrimidine Dehydrogenase Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
7
|
62
|
0.800 |
strong |
0.941 |
51 |
62
|
1988 |
2019 |
Neoplasms, Glandular and Epithelial
|
group |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Sickle Cell Dactylitis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Chemically-Induced Disorders; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
8
|
7
|
0.020 |
None |
1.000 |
2 |
2
|
2015 |
2018 |
Abnormal eating behavior
|
phenotype |
|
Mental or Behavioral Dysfunction
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Bone marrow depression
|
disease |
Musculoskeletal Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Shyness
|
phenotype |
Behavior and Behavior Mechanisms
|
Social Behavior
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Palmar-plantar erythrodysesthesia syndrome
|
disease |
Skin and Connective Tissue Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
11
|
8
|
0.020 |
None |
1.000 |
2 |
2
|
2015 |
2018 |
Language Delay
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
11
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Semantic-Pragmatic Disorder
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
11
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Locally Advanced Malignant Neoplasm
|
disease |
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Auditory Processing Disorder, Central
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hypokalemic periodic paralysis type 1
|
disease |
|
Disease or Syndrome
|
12
|
24
|
0.020 |
None |
1.000 |
2 |
|
1997 |
1999 |
Benign Paroxysmal Positional Vertigo
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
16
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
recurrent gastric cancer
|
disease |
|
Neoplastic Process
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |